Esther van der Werf is a lecturer in Epidemiology of Primary Care Infectious Diseases and joined the Bristol Medical School of the University of Bristol (UK) and the Centre of Academic Primary Care (CAPC) in 2015. She obtained her PhD from Erasmus University Rotterdam in the Netherlands in 2006 and subsequently worked at University of […]
Integration of complementary medicine in the public healthcare system of the Region of Tuscany, Dr Elio Rossi. Antimicrobial resistance, the contribution of CAM/IM to reduce antibiotic use, Prof Erik Baars. Antibiotic prescription rates, Dr Esther van der Werf. Complementary and alternative medicines for acute respiratory infections: a systematic review of qualitative studies, Dr Merlin Willcox.
08:30 Reception and coffee 09:00 Welcome and introduction Dr Ton Nicolai, EUROCAM spokesperson 09:10 Welcome key note: The policy of integration of Complementary Medicine in public health of the Tuscany Region Dr Elio G. Rossi, Head of the Coordination Center of Complementary Medicine – ASL Tuscany North West 09:20 Methodologies and results of the CAM-JPIAMR
Click on a line for the video Session 1 of the conference: Methodologies and results of the CAM-JPIAMR project Session 2 of the conference: Immediate next steps to be achieved by the end of 2018. Testing of Decision Making Tool prototype with stakeholders, implementation/dissemination strategies, organizational development of CAM DMTs for infections. Session 3 of
Head, Antimicrobial Resistance & Healthcare-Associated Infections (ARHAI) Programme European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. Dominique L. Monnet joined ECDC in October 2007 to lead ECDC’s Disease Programme on Antimicrobial Resistance and Healthcare-Associated Infections. Before joining ECDC, he worked in French hospitals, at the US Centers for Disease Control and Prevention (1993-1995)
One of the key objectives of the European One Health action plan against AMR is to boost research, development and innovation by closing current knowledge gaps, providing novel solutions and tools to prevent and treat infectious diseases. The use of effective and safe non-antibiotic treatments of infections is one of the strategies to support appropriate